PNC Financial Services Group’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
MBAM
PNC Financial Services Group's OPRX Position: Q3 2026 in Review
PNC Financial Services Group reduced its OptimizeRx (OPRX) stake by 0.39% in Q3 2026, selling an estimated $58 and leaving 2,023 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3943.
PNC Financial Services Group first reported a position in OPRX in Q3 2019 and has held it in 15 quarters since. The position peaked at $136K in Q3 2019. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.
- PNC Financial Services Group held 2,023 shares of OptimizeRx worth $16.9K as of Q3 2026.
- PNC Financial Services Group sold 8 OptimizeRx shares in Q3 2026, an estimated $58.
- OptimizeRx made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3943 holding.
- PNC Financial Services Group first reported a position in OptimizeRx in Q3 2019 and has held it in 15 quarters since.
- PNC Financial Services Group's OptimizeRx position peaked at $136K in Q3 2019.
- 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.